A study conducted within the National Patient Centered Clinical Research Network (PCORnet) has found that antibiotic use at less than 24 months of age was associated with slightly higher body weight at 5 years of age. Antibiotic overuse has become a major population health concern, due to the dangers of increasing antibiotic resistance however there
A Scottish Borders-based pharmaceutical firm, Ryboquin has raised £1.3m towards cancer gene therapy drug development. The money will allow Ryboquin Ltd to take the product – named Ryboquin ECP-102 – one step closer to clinical trials. The firm, which has its headquarters in Selkirk, raised £800,000 from investors plus nearly £500,000 in a Scottish Enterprise
Pfizer is reportedly gearing up to test a combination of three cancer drugs in human trials next year. According to the Financial Times, the trial, which will be one of the first to test a trio of immunotherapies, will monitor the safety and efficacy of the combination in patients with solid cancers. Although current immunotherapies
Three new medicines have been granted approval by cost regulators for use on NHS Scotland. The new treatments will offer options to patients for breast cancer, prostate cancer and heart failure. The Scottish Medicines Consortium has now accepted use of Eisai’s Halaven (eribulin) for the treatment of advanced breast cancer in those patients who have
Lilly and Boehringer Ingelheim have launched their biosimilar insulin, called abasaglar, for the UK market. Abasaglar is a biosimilar of Sanofi’s insulin glargine product, Lantus, which achieved $8.43 billion in sales for Sanofi in 2014. Lilly and Boehringer’s diabetes alliance already has several products available in the UK and globally, had the biosimilar approved by
Cost regulators for the NHS in Scotland have endorsed new medicines for the treatment of HIV, asthma and MRSA-related skin infections. The SMC (Scottish Medicines Consortium) put forward Janssen-Cilag’s Rezolsta (darunavir cobicistat) in combination with another antiretroviral as an option for the treatment of HIV-1 infection in adults aged 18 years or older. Rezolsta combines
In the past few years 3D printing has become the next big trend on the horizon and it has now turned its sights onto the pharmaceutical industry… A few days ago the FDA approved the world’s first 3D printed drug; Aprecia’s Spritam and will be used for treating epilepsy. One of the many benefits of
A study conducted at the University of Manchester suggests it may be possible to predict which rheumatoid arthritis (RA) patients will fail to respond to the biologic drugs given to treat them. Biologics are given by injection and they work by stopping particular chemicals in the blood from activating the immune system and attacking the joints.
Cancer Research Technology (CRT) and the Institute of Cancer Research (ICR) announced earlier today that they have partnered with Johnson & Johnson unit, Janssen Biotech, in an agreement to discover a potential new drug for the blood cancer, multiple myeloma. The partnership is aiming to identify molecules and develop them into experimental therapies that block
Prices of medicines should be lower and the high cost of research is a myth, according to GlaxoSmithKline’s boss Sir Andrew Witty. The pharmaceutical industry should be able to charge less for new drugs in the future by passing on efficiencies within R&D to their customers, according to the chief executive of GSK. High prices
